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Abstract
AIM
To investigate the role of minimally invasive surgery 
for gastric cancer and determine surgical, clinical, and 
oncological outcomes.
METHODS
This is a propensity score-matched case-control study, 
comparing three treatment arms: robotic gastrectomy 
(RG), laparoscopic gastrectomy (LG), open gastrectomy 
(OG). Data collection started after sharing a specific 
study protocol. Data were recorded through a tailored 
and protected web-based system. Primary outcomes: 
harvested lymph nodes, estimated blood loss, hospital 
stay, complications rate. Among the secondary out-
comes, there are: operative time, R0 resections, POD 
of mobilization, POD of starting liquid diet and soft 
solid diet. The analysis includes the evaluation of type 
and grade of postoperative complications. Detailed 
information of anastomotic leakages is also provided.
RESULTS
The present analysis was carried out of 1026 gastre-
ctomies. To guarantee homogenous distribution of 
cases, patients in the RG, LG and OG groups were 
1:1:2 matched using a propensity score analysis with 
a caliper = 0.2. The successful matching resulted in 
a total sample of 604 patients (RG = 151; LG = 151; 
OG = 302). The three groups showed no differences 
in all baseline patients characteristics, type of surgery 
(P  = 0.42) and stage of the disease (P  = 0.16). 
Intraoperative blood loss was significantly lower in the 
LG (95.93 ± 119.22) and RG (117.91 ± 68.11) groups 
compared to the OG (127.26 ± 79.50, P  = 0.002). The 
mean number of retrieved lymph nodes was similar 
between the RG (27.78 ± 11.45), LG (24.58 ± 13.56) 
and OG (25.82 ± 12.07) approach. A benefit in favor 
of the minimally invasive approaches was found in 
the length of hospital stay (P  < 0.0001). A similar 
complications rate was found (P  = 0.13). The leakage 
rate was not different (P  = 0.78) between groups.
CONCLUSION
Laparoscopic and robotic surgery can be safely performed 
and proposed as possible alternative to open surgery. 
The main highlighted benefit is a faster postoperative 
functional recovery.
Key words: Gastric cancer; Gastrectomy; Minimally 
invasive surgery; Robotic; Robot-assisted; Laparoscopy
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: The IMIGASTRIC project is a multi-institutional 
study on gastric cancer developed to collect information 
on the surgical, clinical, and oncological features 
of patients undergoing gastrectomy with a robotic, 
laparoscopic, or open approach. A research group was 
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first established in 2014 and after sharing a specific 
study protocol, data collection officially started at 
the end of 2015. A tailored Web-based software was 
developed to standardize information, facilitate the 
process of data collection in a unified multi-institutional 
database, and guarantee the proper storage of pa-
tient’s data. The purpose was to create an international 
registry with a high methodological quality.
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INTRODUCTION
The treatment of gastric cancer is in continuous 
development with the search for new therapeutic 
drugs, radiation therapy, endoscopy, surgery, and 
combined treatments. These modalities are used 
to try to give the patient the best possibility for a 
cure. Treatments are often tailored according to the 
characteristics and stage of the cancer and surgery 
remains one of the main stay treatment[1]. However, 
technologic advance has provided surgeons with 
minimally-invasive and even non-invasive procedures. 
Over the past two decades, gastrectomy has evolved 
toward the use of small surgical incisions with reduced 
trauma to the patient and a faster postoperative 
recovery. Laparoscopy has now spread globally and 
is within reach for most surgical centers. Researchers 
are now focusing on the application of even more 
sophisticated robotic technologies for gastrectomy. 
Robotic surgery, which until a few years ago seemed 
out of reach in many areas due to high costs, is now 
finding ever-increasing support among different 
oncologic surgical centers. 
Gastric surgery is one of the most relevant and 
developed fields of minimally invasive surgery[2]. Al-
though general international support has emerged in its 
application at dedicated centers, practitioners must still 
assess which patients would benefit most from these 
technologies. Other important questions include: What 
are the real benefits? Where do the limits lie? What kind 
of minimally invasive approach is preferable? 
To date, no international guidelines exist to answer 
these questions, and the role of different minimally 
invasive techniques remains unclear. As a result, the 
institutes themselves, and sometimes the individual 
surgeons, take their own direction. 
In 2014, a research group was established[3] with 
the intent to further investigate these issues. So a first 
phase of data collection from the participating centers 
began with the entering of information into a well-
planned registry. 
This study aimed to report the findings that can be 
assessed from the data collected up to date, comparing 
minimally invasive techniques (laparoscopic and robotic) 
with traditional open surgery.
MATERIALS AND METHODS
Type of study
This is a multi-institutional propensity score-matched 
case-control study, comparing three treatment arms. 
Data collection started after sharing a specific study 
protocol[4].
The study was registered at clinical trials.gov with a 
registration number of NCT02325453.
Groups and interventions
We defined the following groups of comparison: (1) 
Laparoscopic gastrectomy (LG): Patients underwent 
minimally invasive gastrectomy through traditional 
laparoscopic devices; (2) Robotic gastrectomy (RG): 
Patients underwent minimally invasive gastrectomy 
with the assistance of the “Da Vinci” robotic surgical 
system, which allows a surgeon to perform the proce-
dure through a console and dedicated devices; and 
(3) Open gastrectomy (OG): Patients underwent 
gastrectomy with the traditional open approach.
Time period and sites
Data entered into the IMIGASTRIC registry regarding 
procedures performed until data extraction (January 
2016) were analyzed. All involved centers are referral 
institutions with a well-established gastric cancer 
program and experience in minimally invasive surgery. 
All diagnostic and surgical interventions at these 
centers were done according to international guidelines 
and information stored in institutional prospective data 
collection systems.
Eligibility
Specific criteria were considered before starting data 
collection and reported in the study protocol.
Inclusion criteria: Gastric cancer reported in the biopsy 
report, upper endoscopy and CT scan for staging, both 
Early Gastric Cancer[5,6] and Advanced Gastric Cancer[5,6] 
were considered, curative surgery[7-9].
Exclusion criteria: Evidence of metastatic disease, 
ASA score > 4, history of other surgery for gastric 
cancer, other malignancy, surgery with palliative intent.
Reported information and outcomes: This study 
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of the surgical procedure. Errors related to the trans-
mission of data in a single registry were minimized by 
the creation of a dedicated IT tool with standardized 
fields by which information was collected and analyzed. 
International classifications and guidelines and shared 
measurement units were considered before starting the 
data collection phase to avoid heterogeneity.
The present study was reported in accordance with 
the STROBE guidelines and statement[11]. 
Propensity score matching
Propensity score matching analysis was carried out 
using SPSS software version 23 and R software version 
3.1, through the Custom Dialog “PS Matching”. A value 
for each patient was calculated based on the covariates 
of sex, age, comorbidities, BMI, stage of disease, type 
of gastrectomy. Then, patients in the RG, LG and OG 
group were 1:1:2 matched considering a caliper = 0.2.
Statistical analysis
IBM SPSS Statistics V.23 was used to carry out the 
statistical analysis. An intention to treat analysis was 
performed.
Numbers and percentages were used to report 
dichotomous variables. Continuous variables were 
expressed as mean ± SD and median with IQR. 
One-way ANOVA analysis of variance with post hoc 
multiple comparison adopting the Tukey’s procedure 
was used to allow the comparison among the three 
groups for continuous variables. Values from categorical 
variables were compared between groups through the 
Pearson’s χ2 and the Fisher’s exact test. Then, the Z 
test with the Bonferroni correction was used to evaluate 
statistical significance among the Robotic, Laparoscopic 
and Open approaches. Statistical significance was set at 
a P value < 0.05.
RESULTS
Patients and group characteristics
At the time of this analysis, 1026 patients had been 
entered in the IMIGASTRIC registry. Among them, 44% 
underwent minimally invasive procedures, of which 
227 patients (22%) had their procedure performed by 
laparoscopy and 222 (22%) by the robotic system.
The matching analysis resulted in a total sample of 
604 patients, 151 from RG group, 151 from LG group, 
302 patients from OG group.  The successful matching 
permitted to obtain a homogeneous distribution of 
all patient’s characteristics, surgeries performed and 
stage of the disease (Tables 1 and 2).
Particularly, the three groups exhibited similar 
distribution of baseline patient characteristics (Table 1) 
with regard to age (P = 0.14), gender (P = 0.26), BMI 
(P = 0.31), ASA (P = 0.18), comorbidities (P = 0.96).
The details of the surgical procedures performed and 
the tumor features are shown in Table 2. The groups 
showed no significant differences in the distribution 
of cases regarding type of gastrectomy (P = 0.42), 
reported descriptive findings and outcomes among 
the three groups. The first part comprises three 
sections: basic patient characteristics, tumor findings, 
and surgical procedure details. The outcomes section 
offers a comparison regarding operative results, 
postoperative recovery, and complications:
Primary outcomes: No. of harvested lymph nodes 
(mean ± SD), estimated blood loss (EBL; mean ± SD), 
hospital stay (mean ± SD), and overall complications 
(no. patients, %). 
Secondary outcomes: Operative time (mean ± SD), 
curative resection (R0; no. patients, %), intraoperative 
blood transfusion (no. patients, %), intraoperative 
complications (no. patients, %), intraoperative death 
(no. patients, %), post-operative day (POD) of patient 
mobilization (mean ± SD), POD of starting liquid diet 
(mean ± SD), POD of starting soft solid diet (mean ± 
SD), POD of resumption of peristalsis (mean ± SD), 
POD of first flatus (mean ± SD), length of intravenous 
antibiotic use (mean ± SD), length of intravenous 
analgesic use (mean ± SD), and post-operative 
transfusion (no. patients, %).
A deeper analysis of complications was reported, 
including the type of complications, the number related 
and not related to surgery, and the grade based on the 
Clavien-Dindo classification[10]. A specific analysis of 
anastomotic leakage was also reported.
Source of data analyzed
Investigators collected data through a web-based 
system (https://imigastric.logix-software.it/). Then 
data were extracted using pre-established IT tools. 
Potential bias and study limitations
The retrospective approach is a major limitation for 
this study, but the propensity score case-matched 
analysis allowed us to determine a homogeneous 
distribution of cases.
Potential bias and study limitations reflect those 
related to this type of study, particularly the potential 
lack of information in medical records analyzed and 
errors in filling in the clinical diary or the description 
Table 1  Characteristics of patients n  (%)
Open Laparoscopy Robotic P  value
Total 302 151 151
Age 67.19 ± 13.1   65.82 ± 14.16   68.81 ± 12.12 0.14
BMI 24.33 ± 3.65 24.02 ± 2.22 24.58 ± 3.00 0.31
Sex 0.26
   Female 117 (38.7) 66 (43.7) 70 (46.4)
   Man 185 (61.3) 85 (56.3) 81 (53.6)
ASA 0.18
   Ⅰ 66 (21.9) 23 (15.2) 26 (17.2)
   Ⅱ 139 (46.0) 64 (42.4) 73 (48.3)
   Ⅲ 97 (32.1) 64 (42.4) 52 (34.4)
Comorbidities 192 (63.6) 96 (63.6) 95 (62.9) 0.96
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reconstruction performed (P = 0.1), lymphadenectomy 
(P = 0.32), tumor location (0.57), stage of the disease (P 
= 0.16) and rate of undifferentiated tumors (P = 0.46).
Operative outcomes
The operative time was significantly longer in the RG 
than the other two groups (P <  0.0001). A statistical 
difference in favor of the OG was also observed when 
compared with the LG (P = 0.01) (Table 3).
A reduction in the Estimated Blood Loss (EBL) 
resulted in favor of both of the minimally invasive 
approaches vs the OG (P = 0.002) and particularly 
slightly in favor of the LG when compared with the RG 
(P = 0.04). However, the need for intraoperative blood 
transfusion did not differ among the groups (P = 0.56).
Regarding the number of harvested lymph nodes, 
each group confirmed to guarantee an adequate 
number of harvested lymph nodes for pathological 
assessment and no statistical significant differences 
were found in the comparison among groups (P = 
0.07).
The conversion rate was 5.3% (n = 8) in the LG and 
4.6% (n = 7) in the RG with no significant difference (P 
= 0.5).
Clinical recovery outcomes 
A significantly shorter hospital stay (P < 0.0001) was 
found in both of the minimally invasive groups vs the 
Table 2  Details of surgical procedures and tumour pathology n  (%)
Open Laparoscopy Robotic P  value
Type of gastrectomy 0.42
   Distal 205 (67.9) 102 (67.5) 111 (73.5)
   Total 97 (32.1) 49 (32.5) 40 (26.5)
Type of reconstruction 0.10
   Billroth Ⅰ/Ⅱ 88 (29.1) 31 (20.5) 51 (33.8)
   Roux-en-Y G-J 117 (38.7) 70 (46.4) 60 (39.7)
   Roux-en-Y E-J 97 (32.1) 50 (33.1) 40 (26.5)
D2 Lymphadenectomy 294 (97.4) 144 (95.4) 143 (94.7) 0.32
Position 0.57
   Lower third 153 (50.7) 76 (50.3) 84 (55.6)
   Middle third 108 (35.8) 54 (35.8) 54 (35.8)
   Upper third 41 (13.6) 21 (13.9) 13 (8.6)
Pathologic stage 0.16
   0 19 (6.3) 4 (2.6) 4 (2.6)
   ⅠA 76 (25.2) 54 (35.8) 54 (35.8)
   ⅠB 48 (15.9) 27 (17.9) 27 (17.9)
   ⅡA 55 (18.2) 14 (9.3) 14 (9.3)
   ⅡB 28 (9.3) 14 (9.3) 14 (9.3)
   ⅢA 24 (7.9) 12 (7.9) 12 (7.9)
   ⅢB 34 (11.3) 17 (11.3) 17 (11.3)
   ⅢC 18 (6) 9 (6) 9 (6)
Undifferentiated carcinoma 115 (38.1) 65 (43.0) 55 (36.4) 0.46
Table 3  Surgical and post-operative clinical outcomes n  (%)
Open Laparoscopy Robotic P  value
Operative time (min) 198.67 ± 59.66 220.37 ± 91.89 365.44 ± 80.92 < 0.0001
EBL (mL) 127.26 ± 79.50     95.93 ± 119.22 117.91 ± 68.11     0.002
LN retrieved   25.82 ± 12.07   24.58 ± 13.56   27.78 ± 11.45   0.07
R0 resections 287 (95.0) 145 (96.0) 148 (98.0)   0.59
Intraoperative blood transfusion 9 (3) 7 (4.6) 4 (2.6)   0.56
Intraoperative complications 5 (1.7) 3 (2) 2 (1.3) 0.9
Hospital stay (d) 12.68 ± 5.88   9.07 ± 9.16   8.85 ± 5.82 < 0.0001
Mobilization (d)   2.36 ± 1.34     2.7 ± 1.51   1.42 ± 1.27 < 0.0001
Liquid diet (d)   5.79 ± 3.30   4.12 ± 3.37   3.21 ± 2.49 < 0.0001
Soft solid diet (d)   8.36 ± 5.45   5.73 ± 7.00   4.23 ± 3.79 < 0.0001
Resumption of peristalsis (d)   2.64 ± 0.67   2.52 ± 0.68   2.35 ± 1.16     0.003
First flatus (d)   4.01 ± 1.05   3.75 ± 0.76   3.23 ± 1.33 < 0.0001
Drain removal (d)     8.5 ± 3.55   6.44 ± 4.61   6.05 ± 8.69 < 0.0001
NG removal (d)   4.92 ± 1.88   3.98 ± 1.74   2.82 ± 2.01 < 0.0001
Intravenous antibiotic use (d)   6.13 ± 3.84   4.58 ± 3.52   3.92 ± 4.27 < 0.0001
Intravenous analgesic use (d)   3.79 ± 1.48     2.9 ± 0.91   3.44 ± 1.78 < 0.0001
Post-operative transfusion 19 (6.3) 13 (8.6) 13 (8.6)   0.56
Complications (patients) 59 (19.5) 18 (11.9) 27 (17.9)   0.13
EBL: Estimated blood loss; LN: Lymph nodes; NG: Nasogastric tube.
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OG, without differences between the LG and RG (P = 
0.97).
All steps in the patients’ recovery status happened 
faster in both of the minimally invasive approaches 
than the open surgery (Table 3). A small benefit was 
found to be significant in the minimally invasive groups 
vs the OG in intravenous antibiotic and analgesic 
discontinuation (P < 0.0001). Data on post-operative 
blood transfusion did not differ among the groups (P = 
0.56).
Analysis of complications 
The number of patients experienced complications did 
not differ among the three groups (P = 0.13), as well 
as no differences were found regarding the different 
types of complications (P = 0.052). The most frequently 
observed complications included leakage, bleeding 
(intraluminal and intra-abdominal), and pancreatic 
fistula. Among the medical complications, pneumonia 
and urinary complications were most common (Table 4).
No differences with regard to the distribution of 
surgical and non-surgical complications (P = 0.29) 
were assessed between the groups.
Overall, no differences were found when considering 
the grade of complications, based on the Clavien-Dindo 
scale (0.11). Most of the complications experienced by 
each group were grade Ⅰ or Ⅱ (76.9%, overall). The 
number of patients requiring reoperation did not differ 
among the three groups (P = 0.38).
Analysis of leakage 
Anastomotic leakage was the most relevant complication 
reported. The leakage rate was not different (P = 
0.78) between LG (2.6%), RG (2.6%) and OG (3.6%). 
Therefore, further analysis is reported. The distribution 
of the leakage by different anastomotic sites was similar 
among the groups (P = 0.36). In 36.84% of cases, a 
new surgery was required, while 63.16% of cases were 
managed with total parenteral nutrition and abdominal 
drainage. The leak-related reoperation rate did not differ 
Table 4  Analysis of post-operative complications n  (%)
Type of complication Open Laparoscopy Robotic Total
Anastomotic stenosis   1   1   1     3
Arrhythmias   1   1   2     4
Cerebral vascular accident   0   0   1     1
Congestive heart failure   1   0   0     1
Delayed gastric emptying   3   0   0     3
Dumping syndrome   3   0   0     3
Fluid collection/abscess   4   1   0     5
Intestinal obstruction   2   3   0     5
Intra-abdominal bleeding   2   0   4     6
Intraluminal bleeding   3   2   3     8
Leak 11   4   4   19
Myocardial infarction   2   0   0     2
Pancreatic fistula   2   0   4     6
Peritonitis   1   0   0     0
Pleural effusion   3   0   0     3
Pneumonia   8   1   4   13
Pulmonary edema   1   0   0     1
Pulmonary embolism   0   0   1     1
Remnant stomach necrosis   0   1   0     1
Sepsis   4   0   1     5
Urinary   3   3   0     6
Wound infection   0   1   0     1
Other 13   1   2   16
Total no. of complications 68 19 30 117
Non-surgical related 32 (47.1) 6 (31.6) 10 (33.3) 48 (41.03)
Surgical-related 36 (52.9) 13 (68.4) 20 (66.7) 69 (58.97)
Clavien dindo grade
   Ⅰ + Ⅱ 50 (73.5) 12 (63.2) 28 (93.3) 90 (76.9)
   Ⅲa 3 (4.4) 2 (10.5) 0 (0.0) 5 (4.3)
   Ⅲb 11 (16.2) 5 (26.3) 2 (5.7) 18 (15.4)
   Ⅳ 4 (5.9) 0 (0.0) 0 (0.0) 4 (3.4)
Leakage rate 11 (3.6) 4 (2.6) 4 (2.6)
Reoperation 11 (3.6) 5 (3.3) 2 (1.3)
Analysis of leakage
Leakage rate 11 (3.6) 4 (2.6) 4 (2.6)
Site of leak
   Duodenal stump   4   1   2     7
   Esophagojejunostomy   4   3   0     7
   Gastroduodenostomy   1   0   0     1
   Gastrojejunostomy   2   0   2     4
Leak-related reoperation 5 (1.7) 2 (1.3) 0 (0.0)
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among the three groups (P = 0.29)(Table 4).
DISCUSSION
The present study has analyzed data on gastrectomies 
coming from a large registry, after sharing a specific 
protocol and using a tailored web-based software. It 
represents the first attempt to establish an international 
project for gastric cancer on minimally invasive surgery. 
It includes both the robotic and laparoscopic surgery, 
and the open approach as control group.
To date, only three publications[12-14] in the literature 
report a three-arms comparison among open surgery, 
laparoscopic, and robotic surgery. None of these 
reports feature Western patients, and two come from 
a Korean database[13-15]. All other existing studies 
show a series of robotic surgeries compared only with 
laparoscopy, except one study that compared the 
robotic with the open approach[16]. The current gold 
standard remains open surgery, so any comparison 
in the short and long term should consider a control 
group of open surgery. The potential benefits and di-
fferences between laparoscopic vs robotic techniques 
are unclear, and for robotic surgery, a gap exists in 
strong evidence and well-designed studies. Currently, 
the main international guidelines[1,7] of management 
of gastric cancer do not discuss the robotic technology, 
although many centers are utilizing robotic gastrectomy 
for the treatment of gastric cancer in the past decade. 
Scientific evidence for the role of laparoscopic and 
robotic gastrectomy is not keeping pace with these 
technological developments. The current study includes 
information to gain an understanding on the use of 
minimally invasive surgical techniques and their impact 
on surgical practice[3,4]. The goal of this study was to 
gather data to examine the actual role of minimally 
invasive surgery. 
Among the intraoperative outcomes, this study 
confirms lower blood loss in the minimally invasive 
approaches compared to the open approach (P = 
0.002). Within the minimally invasive techniques, 
there was lower blood loss in the LG. Viñuela et al[17], 
in his meta-analysis, showed similar findings with a 
significantly lower blood loss in the LG vs OG. In Kang’s 
study[18], the RG had lesser EBL than the LG, especially 
for technically demanding lymph node stations (93.25 
mL vs 173.45 mL, P <  0.001). Junfeng et al[19] high-
lighted that the RG group had a smaller amount of EBL 
in elderly patients (101.4 mL vs 131.4 mL, P = 0.017). 
The general consensus among different studies is the 
advantage of robotic surgery over laparoscopy and 
open surgery in reducing operative bleeding. However, 
researchers have not achieved full agreement on this 
aspect, as shown by Eom et al[20] (RG: 152.8 mL vs 
LG: 88.3 mL, P = 0.09) and Son et al[21] (RG: 173.2 mL 
vs LG: 116.6 mL, P = 0.014). The results of these two 
studies are closer to our reported analysis. 
We observed a significantly high operative time 
with the robotic approach (P < 0.0001). This appears 
not entirely justifiable by the docking time and other 
factors likely come into play. The conversion rate to 
open surgery does not differ (P = 0.5), demonstrating 
the substantial equivalence of both techniques in being 
able to complete the minimally invasive procedure. 
Studies[17,22] in the literature have widely discussed and 
reported results in terms of the safety and feasibility 
of minimally invasive procedures for gastrectomy. The 
present study confirms the overall low rate of intra-
operative complications with no statistical differences 
vs open surgery (P = 0.9). 
The most relevant issue is definitely ensuring 
proper oncological surgery by performing an adequate 
lymphadenectomy with minimally invasive approaches. 
Researchers still regard nodal clearance as an important 
factor influencing long-term survival. Viñuela et al[17] 
showed a significant higher number of lymph nodes 
retrieved in the OG than in the LG by 3.9 nodes (P < 
0.001), while no significant difference was found in 
ensuring a proper number of lymph nodes (> 15 Lns) 
for pathological stage assessment (P = 0.09). 
Laparoscopy has shown to require a long learning 
curve and experience to perform an extended lympha-
denectomy, when required. 
Robotic surgery can facilitate better D2 dissection. 
This advanced technology clearly possesses intrinsic 
advantages for this surgical step, but researchers 
have not yet proven and verified them through appro-
priate trials: Overall, only four studies[12-14,16] have 
compared robotic surgery with the open approach on 
this outcome. In particular, Kim MC’s study[14] does 
not report a significant difference among the three 
surgical groups, in contrast with Huang[12] and Kim KM’s 
study[13]. Caruso et al[16] reported a significant difference 
between robotic and open surgery, but the robotic 
sample is too small to draw conclusions. Among studies 
comparing the two minimally invasive techniques, only 
one study[19] was able to show a statistically significant 
benefit in favor of robotic surgery. However, in the latter 
study[19], the researcher did not report in the published 
paper the number of D2 procedures in the two groups. 
In the present study, the oncological success of the 
procedures shows a balance between the three 
approaches regarding the residual tumor assessment 
(P = 0.59). The rates of infiltrated margins were low in 
all performed procedures, demonstrating the success of 
surgeries performed in referral centers. If one considers 
the outcomes above alongside the number of retrieved 
lymph nodes robotic surgery seems to net comparable 
outcomes to those of open surgery. 
In the analysis of the post-operative course, the 
number of overall complications was lower in the 
LG than OG group, in Viñuela's study[17] (P < 0.001). 
Particularly, significant advantages were found in 
medical and minor surgical complications. However, no 
differences were seen for major surgical complications 
in this study, while the current largest RCT (KLASS 
Trial)[23] didn’t show any differences between LG and OG 
(P = 0.13) in the assessment of overall postoperative 
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complications. 
Researchers have obtained inconsistent findings in 
studies on robotic surgery in terms of demonstrating 
differences compared to laparoscopy in the analysis 
of complications[22]. Hyun et al[24], in his comparison 
between RG and LG, reported similar results regarding 
overall complications (P = 0.36), but with a higher rate 
of patients experiencing grade IIIa and IIIb (Clavien-
Dindo) complications in the laparoscopic group. Son 
et al[21] showed no significant differences in the number 
(P = 0.37) and severity (P = 0.88) of complications 
between the two minimally invasive groups. Park et al[25] 
found a rate in favor of the LG approach, but without 
reaching a significant difference (P = 0.12) and with a 
similar number of severe complications rate (P = 0.25) 
in both groups. In our study, we found no differences in 
the type (P = 0.053) and severity of complications (P = 
0.11) among the three groups. 
Minimally invasive surgery has demonstrated 
relevant advantages over open surgery with regard 
to postoperative hospital stay, despite the extreme 
heterogeneity among studies. A shorter hospital stay 
was reported in LG in Viñuela's study[17] (WMD = 3.6 d, 
95%CI: 2.6-4.5, P < 0.001). 
Previous studies on RG[14,26] have shown that the 
length of hospital stay can be shorter than that of OG 
or LG. Particularly, Woo et al[26] found a significant 
difference (P = 0.04) in the rate of patients discharged 
within the fifth postoperative day in favor of the robotic 
approach (61%).
Several factors were hypothesized regarding the 
inflammatory response after surgery, as for example a 
lesser tissues manipulation in robotic surgery[27]. Thus, 
postoperative bowel recovery in the RG may be shorter 
than other approaches. Moreover, Song et al[28] and 
Park et al[25] showed some advantages in the RG group 
regarding ambulation, pain control and postoperative 
hospital stay. However, differences can be seen 
among the published studies in the literature. Junfeng 
et al[19] didn’t show differences between the two 
groups regarding first flatus, time to start a liquid diet, 
and postoperative length of stay. Son et al[21] found 
advantages in favor of LG in terms of postoperative 
restoration of bowel function, resumption of oral 
intake, and hospital stay. Kang et al[18] reported a 
significant longer hospitalization in the RG than the LG 
group, with a mean difference of 1.7 d (P = 0.042).
Our analysis showed a statistically significant 
advantage in hospitalization (P < 0.0001) with the 
minimally invasive approaches without differences 
between the LG and RG, as well as benefits in all 
patients’ functional recovery steps.
Technological developments have made now possible 
the use of minimally invasive surgery for gastric cancer. 
Several points remain object of debate as the role 
of the Enhanced Recovery After Surgery protocols, the 
spread of the robotic system and its cost that, to date, 
is not comparable to that of traditional laparoscopy. 
Minimally invasive surgery is safe in ensuring 
a proper gastric oncological procedure with some 
advantages in the postoperative period, but undou-
btedly, the best possible strategy should be tailored 
on the characteristics of the patient and the stage of 
disease.
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